3648 results for «478»

Filter By

3648 results

Assessing coronaries in ACS with intracoronary imaging

21 May 2026 – From EuroPCR 2026

This session highlights the critical role of intracoronary imaging in evaluating acute coronary syndromes (ACS). It discusses the management of complex lesion morphologies involving calcium and thrombus, the diagnostic power of OCT in decision-making, challenges beyond angiography in right coronary artery pathology, and the identification of...

TAVI sub-studies - Beyond the primary endpoint

21 May 2026 – From EuroPCR 2026

This session reviews key sub-studies from major TAVI trials that extend beyond primary endpoints to provide a deeper understanding of valve performance and patient outcomes. It covers comparisons between balloon-expandable and self-expanding valves, long-term real-world data on the Myval valve, echocardiographic outcomes, composite endpoint analyses, and...

TAVI sub-studies - Beyond the primary endpoint

Diagnosis and management of INOCA and ANOCA

21 May 2026 – From EuroPCR 2026

This session focuses on the diagnosis and management of ischemia and angina with non-obstructive coronary arteries (INOCA and ANOCA). It presents safety data from coronary function testing, patient outcomes after comprehensive ischemia assessment, and endotype-specific treatment effects. Further topics include coronary sinus reducer therapy, the impact...

New evidence in coronary physiology for microvascular assessment

21 May 2026 – From EuroPCR 2026

This session highlights new evidence in coronary physiology related to microvascular assessment. Topics include endothelial dysfunction in angina with non-obstructive arteries, the prognostic value of microvascular resistance metrics, natural history studies, and trials aimed at standardizing management of microvascular dysfunction.

New evidence in coronary physiology for microvascular assessment

Effect of myocardial viability, percutaneous coronary intervention and functional recovery on clinical outcomes in the REVIVED-BCIS2 randomized trial

13 Mar 2023

Dejan Milasinovic provides his take on this clinical trial which was presented by Divaka Perera (London, United Kingdom), at the American College of Cardiology (ACC/WCC) 2023 Scientific Session.

Dejan Milasinovic

Author

Dejan Milasinovic
Effect of myocardial viability, percutaneous coronary intervention and functional recovery on clinical outcomes in the REVIVED-BCIS2 randomized trial

News regarding the SIRONA Randomized Trial

10 Feb 2022

Outcomes in patients with atrial fibrillation randomized to receive LAA closure or oral anticoagulation: Primary results of the CHAMPION-AF clinical trial

28 Mar 2026

During the first Late-Breaking Trial session of the 2026 ACC Congress held in New Orleans, Saibal Kar, principal investigator of the CHAMPION-AF trial, presented the 3-year results of this groundbreaking study, which were simultaneously published in the NEJM (DOI: 10.1056/NEJMoa2517213).

Luigi Biasco

Author

Luigi Biasco
CHAMPION-AF: LAAC vs oral anticoagulation in atrial fibrillation

Transcatheter edge-to-edge repair in patients with severe mitral regurgitation and cardiogenic shock: Insights from the TVT Registry

17 Sep 2022

Mirvat Alasnag provides her take on the TEER Shock study which was presented at TCT 2022 by Mohamad A. Alkhouli.

Dr. Mirvat Alasnag

Author

Mirvat Alasnag
Transcatheter Edge-to-Edge Repair in Patients With Severe Mitral Regurgitation and Cardiogenic Shock: Insights From the TVT Registry
Didn’t find what you were looking for?